Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | IGF2R | P11717 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17974033 | 1.00 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL23031881 | 1.00 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL17519161 | 1.00 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL18610577 | 1.00 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL22639112 | 0.95 | MAPK1 (0.46) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL24105620 | 0.95 | MAPK1 (0.44) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL16920715 | 0.95 | ESR1 (0.47) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL21207336 | 0.95 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL21086224 | 0.95 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 | |
| SCHEMBL23730428 | 0.95 | MAPK1 (0.48) | MAPK1MEN1KMT2AANPEPESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357773-A1 | OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS | HOFFMANN-LA ROCHE INC. | 2023-11-09 | — | — | US | disclosed |
| US-10829555-B2 | Oligonucleotides for reduction of PD-L1 expression | HOFFMAN-LA ROCHE INC. (US) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829555-B2 | Oligonucleotides for reduction of PD-L1 expression | CD274, PDCD1LG2, PDCD1 | MAPK1 2836/4885MEN1 2891/4885KMT2A 848/4885 |
| US-20230357773-A1 | OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS | HAVCR2, DCLRE1B, NSUN2 | MAPK1 4634/4885MEN1 4465/4885KMT2A 3082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.